Steve Pakola
Chief Medical Officer at REGENXBIO Inc. (RGNX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $940K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 6SEC | RGNXREGENXBIO Inc. | Sell Plan | 2,161213,009 held (−1%) | $13.64 | $29K | -40.8% |
| Jul 1SEC | RGNXREGENXBIO Inc. | Sell Plan | 19,608213,009 held (−8%) | $11.04 | $216K | -26.9% |
| Jul 1SEC | RGNXREGENXBIO Inc. | Sell Plan | 36,725213,009 held (−15%) | $12.86 | $472K | -37.2% |
| May 13SEC | RGNXREGENXBIO Inc. | Sell Plan | 15,309232,617 held (−6%) | $11.02 | $169K | -26.8% |
| Mar 12SEC | RGNXREGENXBIO Inc. | Sell Plan | 5,124247,926 held (−2%) | $10.35 | $53K | -22.0% |
- Sell
Chief Medical Officer Steve Pakola sold $29K of RGNX at $13.64 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Steve Pakola sold $216K of RGNX at $11.04 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Steve Pakola sold $472K of RGNX at $12.86 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Steve Pakola sold $169K of RGNX at $11.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Steve Pakola sold $53K of RGNX at $10.35 — pre-scheduled 10b5-1 plan sale.